Clinical Trial

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

Study acronym: Myo-Bleed
Recruiting
View on ClinicalTrials.gov →
Summary
This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-16; most recent amendment 2026-05-12.
Status change: Not Yet Recruiting → Recruiting 2026-05-12
Trial Details
NCT Number NCT07182045
Lead Sponsor The University of Texas Health Science Center, Houston
Conditions Myoma, Surgery
Enrollment 120 participants
Start Date 2025-09-18
Primary Completion 2028-09-30 (estimated)
Study Completion 2029-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-14